Identification of a novel DHCR7 mutation in a Korean patient with Smith-Lemli-Opitz syndrome.
Smith-Lemli-Opitz syndrome is a unique malformation syndrome characterized by a defect in cholesterol biosynthesis, which is very rare among populations in Middle and East Asia. The authors identified compound heterozygous mutations ([p.Arg352Trp] + [p.Lys376ArgfsX37]) in a Korean girl with clinical and laboratory features typical of Smith-Lemli-Opitz syndrome. The Lys376ArgfsX37 mutation is a novel mutation, and to the best of the authors' knowledge, this is the first report of a clinically and genetically confirmed case of Smith-Lemli-Opitz syndrome in Korea.
Jong Hee Chae
Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.
Ki Joong Kim
Yong Seung Hwang
Ki
Chang-Seok
CS
Kim
Jong-Won
JW
D001120:Arginine / Q000235:genetics; D004252:DNA Mutational Analysis; D005260:Female; D006801:Humans; D007223:Infant; D007723:Korea; D008239:Lysine / Q000235:genetics; D009154:Mutation; D044925:Oxidoreductases Acting on CH-CH Group Donors / Q000235:genetics*; D019082:Smith-Lemli-Opitz Syndrome / Q000235:genetics* / Q000473:pathology
D001120:Arginine; D044925:Oxidoreductases Acting on CH-CH Group Donors; C019995:7-dehydrocholesterol reductase; D008239:Lysine